Correlation Between Pacira BioSciences, and Taisho Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Pacira BioSciences, and Taisho Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pacira BioSciences, and Taisho Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pacira BioSciences, and Taisho Pharmaceutical Holdings, you can compare the effects of market volatilities on Pacira BioSciences, and Taisho Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pacira BioSciences, with a short position of Taisho Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pacira BioSciences, and Taisho Pharmaceutical.

Diversification Opportunities for Pacira BioSciences, and Taisho Pharmaceutical

-0.07

Correlation Coefficient

Pacira BioSciences,  Taisho Pharmaceutical

Good diversification

The 3 months correlation between Pacira and Taisho is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Pacira BioSciences, and Taisho Pharmaceutical Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taisho Pharmaceutical and Pacira BioSciences, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pacira BioSciences, are associated (or correlated) with Taisho Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taisho Pharmaceutical has no effect on the direction of Pacira BioSciences, i.e., Pacira BioSciences, and Taisho Pharmaceutical go up and down completely randomly.

Pair Corralation between Pacira BioSciences, and Taisho Pharmaceutical

If you would invest  1,465  in Pacira BioSciences, on September 18, 2024 and sell it today you would earn a total of  522.00  from holding Pacira BioSciences, or generate 35.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.59%
Values	Daily Returns

Pacira BioSciences,  vs.  Taisho Pharmaceutical Holdings

Pacira BioSciences,

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pacira BioSciences, are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pacira BioSciences, showed solid returns over the last few months and may actually be approaching a breakup point.

Taisho Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Taisho Pharmaceutical Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Taisho Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pacira BioSciences, and Taisho Pharmaceutical

The main advantage of trading using opposite Pacira BioSciences, and Taisho Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pacira BioSciences, position performs unexpectedly, Taisho Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taisho Pharmaceutical will offset losses from the drop in Taisho Pharmaceutical's long position.

The idea behind Pacira BioSciences, and Taisho Pharmaceutical Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.